edoxaban tosylate structure Common Nameedoxaban tosylate CAS Number480449-71-6Molecular Weight720.259 DensityN/ABoiling PointN/A Molecular FormulaC31H38ClN7O7S2Melting PointN/A MSDSN/AFlash PointN/A Use of edoxaban tosylate Edoxaban(DU-176) is an oral factor Xa (FXa) inhibitor in clinical deve...
Edoxaban tosylate monohydrate (CAS 1229194-11-9) information, including chemical properties, structure, melting point, boiling point, density, formula, molecular weight, uses, prices, suppliers, SDS and more, available at Chemicalbook.
Molecular Weight:548.07 公司简介 深圳市洛克医药科技有限公司(Roark Standards)是一家专注于为药物研发机构提供药物标准品、杂质对照品定制合成的服务型企业,同时也为合作对象提供相关化合物的采购工作。 为了更好地服务于客户,我们致力于为客户提供高品质、低成本的产品,并在合作过程中保持对达成双方满意结果的关注。在...
Edoxabantosylate (Lixiana; Daiichi Sankyo, Tokyo, Japan), known as DU-176b inclinical trials, is a novel oraldirect factor Xa inhibitor. Edoxaban has good bioavailability with maximum plasma concentration achieved 1–2h after ingestion and plasma half-life of 8–10h (Ogata et al., 2010). ...
Edoxaban-tosylate-monohydrate-COA-15962-MedChemExpress Inhibitors, Agonists, Screening Libraries www.MedChemExpress.com Certificate of Analysis PHYSICAL AND CHEMICAL PROPERTIES Molecular Formula:C 31H 40ClN 7O 8S 2Molecular Weight:738.27Storage:Powder -20°C 3 years 4°C 2 years In solvent...
(548 Da), reversible factor Xa inhibitor.As with the other direct oral factor Xa inhibitors,edoxaban exhibits a 10,000-fold greater selectivity for factor Xa compared with other serine proteins such as factor VlIa, t-PA, plasmin,or trypsin.Administered as edoxaban tosylate,the compound ...
英文别名(English Synonym) Edoxaban tosylate monohydrate 中文名称(Chinese Name) 依度沙班对甲苯磺酸盐一水化合物 靶点(Target) Thrombin 通路(Pathway) Protease/Metabolic Enzyme CAS号(CAS NO.) 1229194-11-9 分子式(Formula) C31H40ClN7O8S2 分子量(Molecular Weight) ...
So, patients were switched to edoxaban tosylate monohydrate (EDTM) therapy after low molecular weight heparin to shorten the hospitalization period. In response to increase the demand for EDTM, we developed a home-made screen-printed electrode to determine EDTM in its pure form and pharmaceutical ...
Thromboembolism because of coronavirus infection (COVID-19) resulted in increasing the number of sudden deaths after recovery. So, patients were switched to edoxaban tosylate monohydrate (EDTM) therapy after low molecular weight heparin to shorten the hospitalization period. In response to increase the...